PPDPFL

gene
On this page

Summary

PPDPFL (pancreatic progenitor cell differentiation and proliferation factor like, HGNC:31745) is a protein-coding gene on chromosome 8q11.21, encoding Pancreatic progenitor cell differentiation and proliferation factor-like protein (Q8WWR9).

Predicted to be involved in cell differentiation.

Source: NCBI Gene 492307 — RefSeq curated summary.

At a glance

  • GWAS associations: 1
  • Clinical variants (ClinVar): 3 total — 1 pathogenic
  • MANE Select transcript: NM_001256597

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:31745
Approved symbolPPDPFL
Namepancreatic progenitor cell differentiation and proliferation factor like
Location8q11.21
Locus typegene with protein product
StatusApproved
Ensembl geneENSG00000168333
Ensembl biotypeprotein_coding
Entrez492307

Gene structure

Transcript identifiers

Ensembl transcripts: 6 — 6 protein_coding

ENST00000303202, ENST00000399653, ENST00000517663, ENST00000522267, ENST00000957351, ENST00000957352

RefSeq mRNA: 4 — MANE Select: NM_001256597 NM_001007176, NM_001256596, NM_001256597, NM_001256598

CCDS: CCDS47854, CCDS59101, CCDS59102

Canonical transcript exons

ENST00000522267 — 5 exons

ExonStartEnd
ENSE000011512754907423449074333
ENSE000011512824907278749072885
ENSE000011552394907405949074136
ENSE000011552484907234449072482
ENSE000021162704907515249076093

Expression profiles

Bgee: expression breadth ubiquitous, 136 present calls, max score 99.87.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 3.8611 / max 2682.3970, expressed in 52 samples.

FANTOM5 promoters (2 alternative TSS)

Promoter IDTPM avgSamples expressed
888023.851751
888010.00943

Top tissues by expression

245 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
tibialis anteriorUBERON:000138599.87gold quality
deltoidUBERON:000147699.72gold quality
quadriceps femorisUBERON:000137799.57gold quality
vastus lateralisUBERON:000137999.54gold quality
biceps brachiiUBERON:000150799.40gold quality
hindlimb stylopod muscleUBERON:000425299.28gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450299.25gold quality
skeletal muscle tissueUBERON:000113498.95gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451198.38gold quality
gastrocnemiusUBERON:000138897.59gold quality
body of tongueUBERON:001187697.26gold quality
skeletal muscle organUBERON:001489296.79gold quality
muscle of legUBERON:000138396.12gold quality
muscle tissueUBERON:000238589.11gold quality
tongueUBERON:000172387.94gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047385.00gold quality
pharyngeal mucosaUBERON:000035576.82gold quality
superior surface of tongueUBERON:000737174.11gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099171.09gold quality
olfactory segment of nasal mucosaUBERON:000538666.53gold quality
C1 segment of cervical spinal cordUBERON:000646961.39gold quality
subcutaneous adipose tissueUBERON:000219059.49gold quality
spinal cordUBERON:000224059.49gold quality
synovial jointUBERON:000221758.60gold quality
skin of legUBERON:000151158.57gold quality
tibial arteryUBERON:000761058.17gold quality
popliteal arteryUBERON:000225058.12gold quality
jejunumUBERON:000211557.29gold quality
skin of abdomenUBERON:000141656.93gold quality
minor salivary glandUBERON:000183056.66gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.88

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

46 targeting PPDPFL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-656-3P100.0072.152788
HSA-MIR-223-3P99.9970.141140
HSA-MIR-366299.9973.825684
HSA-MIR-314899.9775.066478
HSA-MIR-3688-3P99.9772.022834
HSA-MIR-6888-3P99.9765.951170
HSA-MIR-590-3P99.9674.346478
HSA-MIR-391099.9571.132227
HSA-MIR-314399.9371.963104
HSA-MIR-10523-5P99.9169.222038
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-576-5P99.8470.462582
HSA-MIR-807699.7868.521170
HSA-MIR-7856-5P99.7569.992901
HSA-MIR-494-3P99.7071.452795
HSA-MIR-379-3P99.6969.601524
HSA-MIR-411-3P99.6969.631524
HSA-MIR-128499.6773.561353
HSA-MIR-7157-5P99.6669.331829
HSA-MIR-6762-3P99.6666.941188
HSA-MIR-4743-3P99.6268.122095
HSA-MIR-5003-5P99.6169.131624
HSA-MIR-451699.6167.783390
HSA-MIR-431099.5968.842527
HSA-MIR-432899.5771.064094
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-6740-3P99.4868.491392

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
danio_rerioppdpfaENSDARG00000007682
danio_rerioppdpfbENSDARG00000031317

Paralogs (1): PPDPF (ENSG00000125534)

Protein

Protein identifiers

Pancreatic progenitor cell differentiation and proliferation factor-like proteinQ8WWR9 (reviewed: Q8WWR9)

Alternative names: Exocrine differentiation and proliferation factor-like protein

All UniProt accessions (1): Q8WWR9

UniProt curated annotations — full annotation on UniProt →

Similarity. Belongs to the PPDPF family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8WWR9-11yes
Q8WWR9-22
Q8WWR9-33

RefSeq proteins (4): NP_001007177, NP_001243525, NP_001243526, NP_001243527 (=MANE)

Domains & families (InterPro)

IDNameType
IPR026754PPDPFFamily

Pfam: PF15060

UniProt features (3 total): splice variant 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8WWR9-F161.990.00

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 33 (showing top): chr8q11, FORTSCHEGGER_PHF8_TARGETS_UP, MIR1277_5P, MIR4795_3P, MIR3688_3P, MIR4311, MIR3119, MIR3910, MIR4310, MIR4668_3P, MIR580_5P, MIR7157_5P, MIR5003_5P, MIR379_3P_MIR411_3P, MIR4735_5P

GO Biological Process (2): cell differentiation (GO:0030154), multicellular organism development (GO:0007275)

GO Molecular Function (0):

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular developmental process1
multicellular organismal process1
anatomical structure development1

Protein interactions and networks

STRING

198 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PPDPFLLYPD2Q6UXB3485
PPDPFLASPNATQ8N9F0462
PPDPFLCFAP95Q5VTT2413
PPDPFLNKX6-3A6NJ46399
PPDPFLSPINK6Q6UWN8396
PPDPFLPALM2AKAP2Q9Y2D5387
PPDPFLSVOPLQ8N434348
PPDPFLPPDPFQ9H3Y8331
PPDPFLPCOLCE2Q9UKZ9316
PPDPFLMYOZ3Q8TDC0312
PPDPFLTMEM45BQ96B21299
PPDPFLCPNE6O95741294
PPDPFLTUSC3Q13454279
PPDPFLADAMTS8Q9UP79278
PPDPFLACTN3Q08043275

IntAct

2 interactions, top by confidence:

ABTypeScore
PPDPFLPCBP4psi-mi:“MI:0915”(physical association)0.400

BioGRID (1): PCBP4 (Affinity Capture-MS)

ESM2 similar proteins: A0A1I9LQ12, B1B5D5, B9DGG8, F4HV65, F4J8V5, F4JHN2, O64851, O64852, O82645, P0DO24, Q058N0, Q29PZ2, Q2NND9, Q4PSK3, Q5HZ09, Q5JKN2, Q5NB83, Q5T8I3, Q69P88, Q7XA83, Q84U09, Q8BQS4, Q8GRN0, Q8GY65, Q8GYX2, Q8L7S5, Q8L9W8, Q8S307, Q8S8I1, Q8WWR9, Q945P6, Q94AR4, Q94B71, Q966L3, Q9C593, Q9C690, Q9CA36, Q9CAI2, Q9FJF5, Q9FLX4

Diamond homologs: A4IGU9, B5DGK1, Q0IHF8, Q3ZCB6, Q5PR01, Q6PBI2, Q6PFP3, Q8AVU0, Q8WWR9, Q9CR37, Q9H3Y8, A8E653

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

3 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance0
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
662275NC_000008.10:g.(?48270390)(49987806_?)delPathogenic

SpliceAI

569 predictions. Top by Δscore:

VariantEffectΔscore
8:49074563:TGGAG:Tdonor_gain1.0000
8:49074624:A:Tdonor_gain1.0000
8:49072480:TCGGT:Tdonor_loss0.9900
8:49072483:G:GGdonor_gain0.9900
8:49072483:GT:Gdonor_loss0.9900
8:49072484:T:Gdonor_loss0.9900
8:49072883:GAA:Gdonor_gain0.9900
8:49072886:G:GGdonor_gain0.9900
8:49074057:A:AGacceptor_gain0.9900
8:49074058:G:GGacceptor_gain0.9900
8:49074058:GA:Gacceptor_gain0.9900
8:49074228:TAATA:Tacceptor_loss0.9900
8:49074230:ATAGG:Aacceptor_loss0.9900
8:49074231:TA:Tacceptor_loss0.9900
8:49074232:AG:Aacceptor_gain0.9900
8:49074233:GG:Gacceptor_gain0.9900
8:49074233:GGGTT:Gacceptor_gain0.9900
8:49074564:GGAGA:Gdonor_gain0.9900
8:49074628:GGTC:Gdonor_gain0.9900
8:49072786:GATT:Gacceptor_gain0.9800
8:49072786:GATTA:Gacceptor_gain0.9800
8:49074232:A:AGacceptor_gain0.9800
8:49074233:G:GGacceptor_gain0.9800
8:49074332:GG:Gdonor_gain0.9800
8:49074333:GG:Gdonor_gain0.9800
8:49072478:AATCG:Adonor_gain0.9700
8:49072779:T:Aacceptor_gain0.9700
8:49074331:TGGG:Tdonor_loss0.9700
8:49074332:GGGTG:Gdonor_loss0.9700
8:49074334:G:GAdonor_loss0.9700

AlphaMissense

540 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
8:49074263:T:AW55R0.977
8:49074263:T:CW55R0.977
8:49072855:T:CC9R0.948
8:49072853:G:AG8D0.942
8:49072852:G:CG8R0.933
8:49072883:G:CR18P0.930
8:49072844:C:AP5H0.922
8:49072844:C:TP5L0.921
8:49072841:T:AV4E0.918
8:49072865:C:AA12D0.918
8:49072844:C:GP5R0.915
8:49074265:G:CW55C0.911
8:49074265:G:TW55C0.911
8:49072853:G:TG8V0.909
8:49072857:C:GC9W0.908
8:49072859:T:CL10P0.906
8:49072859:T:AL10H0.889
8:49074276:T:CF59S0.887
8:49072835:C:AA2E0.886
8:49074278:T:CF60L0.883
8:49074280:C:AF60L0.883
8:49074280:C:GF60L0.883
8:49072876:T:GY16D0.881
8:49074275:T:CF59L0.870
8:49074277:T:AF59L0.870
8:49074277:T:GF59L0.870
8:49072877:A:CY16S0.868
8:49074064:A:CS21R0.866
8:49074066:T:AS21R0.866
8:49074066:T:GS21R0.866

dbSNP variants (sampled 300 via entrez): RS1000054243 (8:49063837 G>A,C,T), RS1000360788 (8:49052898 A>C,G,T), RS1000531519 (8:49064160 C>T), RS1000571989 (8:49068429 T>C), RS1000772908 (8:49052631 A>C,G), RS1000900417 (8:49072826 A>G), RS1000903807 (8:49057095 C>T), RS1001136525 (8:49062962 A>G), RS1001201014 (8:49074728 T>A), RS1001215957 (8:49057931 C>T), RS1001412479 (8:49066520 C>T), RS1001703783 (8:49063690 C>T), RS1001853292 (8:49074073 T>C), RS1002181895 (8:49066805 G>A), RS1002220100 (8:49056313 A>C,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

1 associations (top):

StudyTraitp-value
GCST012020_401Serum metabolite levels9.000000e-11

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

14 total (human), top 14 by PubMed support.

ChemicalActions (top 5)PubMed papers
Nickeldecreases expression2
Aflatoxin B1affects expression, increases methylation2
hydroxyhydroquinonedecreases expression1
sodium arseniteincreases expression1
butyraldehydeincreases expression1
S-(1,2-dichlorovinyl)cysteineaffects response to substance, increases expression1
pentanalincreases expression1
Poly(amidoamine)increases expression1
Benzo(a)pyreneaffects methylation1
Lipopolysaccharidesaffects response to substance, increases expression1
Malathionincreases expression1
Silicon Dioxidedecreases expression1
Cyclosporineincreases expression1
Okadaic Aciddecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.